Stay updated on PD-1 Inhibition & Ablation for Advanced HCC Clinical Trial
Sign up to get notified when there's something new on the PD-1 Inhibition & Ablation for Advanced HCC Clinical Trial page.

Latest updates to the PD-1 Inhibition & Ablation for Advanced HCC Clinical Trial page
- Check2 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe webpage has been updated to include a new study on the combination of anti-PD-1 therapy and incomplete thermal ablation for advanced hepatocellular carcinoma (HCC), with a focus on specific patient eligibility criteria and the principal investigator's name. The previous version's detailed background information on PD-1 inhibitors and their efficacy in HCC treatment has been removed.SummaryDifference28%
- Check38 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check74 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference2%
- Check96 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference2%
- Check103 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.1%
Stay in the know with updates to PD-1 Inhibition & Ablation for Advanced HCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PD-1 Inhibition & Ablation for Advanced HCC Clinical Trial page.